(Q38348282)

2 September 2017

Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain (English)

1 reference

2 September 2017

1 reference

5

Lindahl U

1 reference

2 September 2017

Feyzi E

1

1 reference

2 September 2017

Lustig F

2

1 reference

2 September 2017

Fager G

3

1 reference

2 September 2017

Spillmann D

4

1 reference

2 September 2017

Salmivirta M

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

Journal of Biological Chemistry

2 September 2017

1 reference

2 September 2017

272

1 reference

2 September 2017

5518-5524

1 reference

2 September 2017

9

1 reference

Structural characterization of the human platelet-derived growth factor A-chain cDNA and gene: alternative exon usage predicts two different precursor proteins

2 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Platelet-derived growth factor A chain: gene structure, chromosomal location, and basis for alternative mRNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

The alternative-splice isoforms of the PDGF A-chain differ in their ability to associate with the extracellular matrix and to bind heparin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Accumulation of PDGF B and cell-binding forms of PDGF A in the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Proteoglycans: structures and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Alternative splicing determines the binding of platelet-derived growth factor (PDGF-AA) to glycosaminoglycans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Mode of interaction between platelet factor 4 and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Glycosaminoglycans and the regulation of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Molecular organization of the interferon gamma-binding domain in heparan sulphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Studies on heparin degradation. I. Preparation of ( 35 S) sulphamate derivatives for studies on heparin degrading enzymes of mammalian origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Formation of anhydrosugars in the chemical depolymerization of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

The disaccharide composition of heparins and heparan sulfates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Domain structure of heparan sulfates from bovine organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

Analogous alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.9.5518

21 January 2018

Identifiers

DOI

10.1074/JBC.272.9.5518

1 reference

2 September 2017

1 reference